https://www.selleckchem.com/products/odm208.html
Chronic hepatitis B virus (HBV) infection results in a high risk of cirrhosis and its complications cirrhosis decompensation, hepatocellular carcinoma (HCC, the fourth most common cause of cancer-related mortality worldwide), liver transplantation and death. It is now 40 years since development of the first plasmatic vaccine which has been proven to prevent (liver) cancer. To update firstly the molecular and epidemiological aspects of HBV-related HCC and its natural history together with the benefits associated with viral suppression and
Like
Comment
Share
